ArticleThe Pan African medical journal2025
Prevalence and associated factors with non-alcoholic fatty liver disease in a group of obese women in Tunisia.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, often undiagnosed, and its prevalence is closely linked to obesity and diabetes. This study aimed to screen for NAFLD in obese women and identify factors associated with both steatosis and fibrosis. Methods: a cross-sectional study was performed on 40 obese female patients. Data were collected through clinical examination, laboratory tests, anthropometric measurements, dietary survey. The assessment of NAFLD was based on the use of Fibroscan. Results: mean age was 43.56±12.75 years. The majority of the patients (65%) were inactive. The mean duration of obesity was 19.95±12.93 years, and morbid obesity was observed in 45% of the patients. Steatosis was detected in 75% of the population with 38.5% in its advanced stage, while fibrosis was identified in 90% of patients, of which 37.5% were in the advanced stage. Multivariable analysis revealed that the duration of obesity progression was positively associated with both the presence (B=0.12, 95% CI 1.00-1.26; p=0.034) and the severity (B=0.08, 95% CI 1.00-1.17; p=0.029) of steatosis. An active lifestyle was negatively associated with the severity of steatosis (aOR=0.14, 95% CI 0.02-0.80; p=0.027), while fiber deficiency intake was positively associated with the severity of fibrosis (aOR=7.04, 95% CI 1.30-37.88; p=0.023). Conclusion: these findings underscore the importance of early screening for NAFLD in this population and suggest that tailored nutritional management may be beneficial in addressing obesity-related liver conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.